Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Automated Cell Culture Equipment Market Forecast: Value Set To Climb From $2.6 Billion To $4.03 Billion
The automated cell culture equipment market size has experienced swift expansion over the last few years. This market is projected to expand from $2.32 billion in 2025 to reach $2.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. Historically, this expansion has been linked to several factors, including an increase in pharmaceutical and biologics research, a greater need for uniform cell culture results, the broadening of drug discovery pipelines, the growing intricacy of cell-based assays, and the initial integration of laboratory automation.
The automated cell culture equipment market size is projected to experience substantial growth in the coming years, reaching $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. This anticipated expansion during the forecast period is driven by factors such as increased investments in regenerative medicine, the broadening of cell and gene therapy pipelines, a rising need for scalable cell culture solutions, a greater emphasis on minimizing laboratory variability, and the expanding integration of AI-driven lab automation. Key developments expected during this period involve the wider implementation of fully automated cell culture platforms, a surge in the adoption of high-throughput cell processing systems, the increased incorporation of robotics and imaging technologies, the proliferation of closed-system and contamination-controlled workflows, and an intensified focus on reproducibility and process standardization.
Get A Free Sample Report With In-Depth Market Insights:
Automated Cell Culture Equipment Market Demand Drivers Opening New Revenue Streams
The increasing embrace of personalized medicine is anticipated to fuel the expansion of the automated cell culture equipment market in the coming years. Personalized medicine involves customizing medical treatments based on an individual’s genetic, lifestyle, and environmental factors, leading to more precise and effective care. This growing adoption is driven by the development of more efficacious treatments, as therapies are specifically designed for a person’s genetic and biological profile, thereby improving patient outcomes. Automated cell culture equipment supports personalized medicine by delivering accurate, high-throughput, and consistent cell culture processes. These processes are essential for creating therapies tailored to individual patients and for conducting customized drug testing. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, announced that in 2023, the FDA authorized 16 new personalized treatments for patients suffering from rare diseases, which was a considerable jump from the six approved in 2022. Thus, the escalating adoption of personalized medicine is a key factor propelling the automated cell culture equipment market’s growth.
Automated Cell Culture Equipment Market Segment Analysis And Revenue Potential
The automated cell culture equipment market covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Software
2) By Automation Level: Fully Automated Systems, Semi-Automated Systems, Manual Systems With Automation Features
3) By Application: Drug Discovery And Development, Regenerative Medicine, Toxicology Testing, Vaccine Development, Stem Cell Research
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Diagnostics And Testing Laboratories
Subsegments:
1) By Instruments: Automated Cell Culture Systems, Bioreactors, Incubators, Centrifuges, Cell Counters And Analyzers, Liquid Handling Systems, Cell Imaging Systems, Robotic Arms And Manipulators, Cell Harvesting Systems, Filtration And Separation Devices
2) By Consumables: Culture Media, Reagents And Supplements, Microplates And Culture Dishes, Flasks And Bottles, Single-Use Bags And Tubing, Filters And Membranes, Pipette Tips And Cartridges, Cell Culture Inserts, Sterile Connectors And Clamps
3) By Software: Data Management Software, Process Control And Monitoring Software, Laboratory Information Management Systems (LIMS), Image Analysis Software, Workflow Automation Software, Quality Control And Compliance Software, Remote Monitoring And Cloud Integration Tools
Automated Cell Culture Equipment Market Trends Powering Strategic Industry Growth
Leading companies in the automated cell culture equipment market are prioritizing innovations in integrating workflows seamlessly, such as using closed single-use consumable systems. This focus aims to improve process standardization, reduce contamination risks, minimize manual handling, and facilitate efficient scaling from research to clinical production. A closed single-use consumable system is defined as a sterile, disposable setup that consolidates multiple cell culture processes into a single unit, thereby mitigating contamination and enabling reproducible, scalable workflows. For example, in March 2025, Limula SA, a Switzerland-based biotechnology firm specializing in automated solutions for cell therapy manufacturing, unveiled LimONE. This integrated system combines hardware, software, and single-use consumables to streamline and standardize cell culture and processing operations. The introduction of LimONE represents a commercial offering designed for both research and GMP-compliant manufacturing environments. LimONE aids in quicker technology transfer, reduces expenses related to labor and infrastructure, and facilitates the scalable production of advanced cell therapies, including CAR-T and gene-edited stem cells. The system also boosts workflow efficiency and guarantees consistent results across various cell therapy processes. Ultimately, this product launch solidifies Limula’s position in the automated cell culture equipment market and supports adherence to regulations.
Automated Cell Culture Equipment Market Key Players Shaping Industry Direction
Major companies operating in the automated cell culture equipment market are F. Hoffmann-La Roche Ltd, Hitachi Ltd., Merck KGaA, Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Olympus Corporation, Sartorius AG, Eppendorf SE, Tecan Group Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Greiner Bio-One International GmbH, Solida Biotech GmbH, Biostream International B.V., HiMedia Laboratories Pvt. Ltd., Kuhner Shaker AG, Cellexus International Ltd.
View The Full Automated Cell Culture Equipment Market Report:
Automated Cell Culture Equipment Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the automated cell culture equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell culture equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model








